# Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs

> **NCT02940691** · PHASE4 · TERMINATED · sponsor: **Kirby Institute** · enrollment: 32 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Grazoprevir/elbasvir

## Key facts

- **NCT ID:** NCT02940691
- **Lead sponsor:** Kirby Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-05-01
- **Primary completion:** 2018-11-01
- **Final completion:** 2018-11-01
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** Poor recruitment due to new treatments becoming available.
- **Last updated:** 2020-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02940691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02940691, "Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02940691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*